Jones Financial Companies Lllp Seres Therapeutics, Inc. Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 420 shares of MCRB stock, worth $3,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
420
Previous 49
757.14%
Holding current value
$3,066
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MCRB
# of Institutions
65Shares Held
39.5MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$169 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$44.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$12.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$11.8 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$10.6 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $906M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...